A national Life Sciences Strategy for Ireland – an opportunity to improve the health of the nation
:quality(90)/)
At Roche Ireland, we are proud to be part of a world-class life sciences sector that discovers, develops and delivers breakthroughs in pharmaceuticals, medical devices and biotechnology. As the Irish government develops a national Life Sciences Strategy, we believe this is a pivotal opportunity to shape a healthier future for everyone in Ireland – not just by driving skills and economic growth, but by ensuring people can access the innovations they need, when they need them
In this new material, we set out why a patient-centred Life Sciences Strategy matters and how it can improve health outcomes nationwide. We highlight three priorities:
Faster access to innovation: Ireland should be among the quickest in Europe for timely, equitable access to new, proven medicines and technologies—so that patients benefit sooner and clinicians have the best tools to deliver care.
Greater participation in clinical trials: With Ireland’s strong research ecosystem, we can expand clinical trial opportunities so more people can access potential new treatments and help advance science for all.
A digital, interconnected health system: Accelerating secure digitalisation and better use of health data—designed with patients and clinicians—will support smarter decisions, more coordinated care and faster progress.
Roche is committed to working with patients, policymakers, clinicians and partners across Ireland to help make this vision a reality. We invite you to read the leaflet, engage with your organisations and representatives, and join the conversation about a Life Sciences Strategy that delivers both the health and the wealth of our nation.